Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.06.2022 | Case report

Carboplatin/paclitaxel

Nausea and vomiting: case report

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Su X, et al. Effects of carboplatin combined with paclitaxel-based intraperitoneal hyperthermic perfusion chemotherapy on serum levels of HE4 and DJ-1 in patients with advanced recurrent ovarian cancer. Pakistan Journal of Medical Sciences 38: 872-877, No. 4, Apr 2022. Available from: URL: http://doi.org/10.12669/pjms.38.4.4736 Su X, et al. Effects of carboplatin combined with paclitaxel-based intraperitoneal hyperthermic perfusion chemotherapy on serum levels of HE4 and DJ-1 in patients with advanced recurrent ovarian cancer. Pakistan Journal of Medical Sciences 38: 872-877, No. 4, Apr 2022. Available from: URL: http://​doi.​org/​10.​12669/​pjms.​38.​4.​4736
Metadaten
Titel
Carboplatin/paclitaxel
Nausea and vomiting: case report
Publikationsdatum
01.06.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-16446-9

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

Isavuconazonium

Case report

Thiamazole